• Skip to main content
  • Skip to primary sidebar
  • Home
  • Categories
  • Authors
  • Print Versions
  • About
  • Masthead
    • 2022-2023
    • 2016-2017

The Bowdoin Review

The Legal Battle Over GMOs

Written by: Madeline Cole '16
Published on: November 17, 2013

The Legal Battle Over GMOs
Photo courtesy of CT Senate Democrats

Walking into a grocery store, a consumer can learn just about any nutritional fact her heart desires– from percent daily iron levels to relative content of monocalcium phosphate–with the flip of a package. And yet, it is nearly impossible to discern exactly which foods contain genetically modified components. The Institute for Responsible Technology defines genetic modification as “a laboratory process where genes from the DNA of one species are extracted and artificially forced into the genes of an unrelated plant or animal.” The resulting genetically modified organisms (GMOs) are becoming increasingly prevalent–in fact, according to the Grocery Manufacturers Association, 70-80 percent of conventional processed foods in the United States contain genetically modified components. To the dismay of a growing number of consumers, they are becoming increasingly infused (and hidden) in everyday food products.  Aside from a tiny portion of brands whose labels boast “GMO-Free!” American consumers have no definite way of avoiding these products, if they desire to do so.

And many American consumers do. In fact, a significant majority of Americans repeatedly poll in favor of GMO-labeling regulations. In Washington, the GMO labeling debate is heating up with a new proposition on the general elections ballot, taking place November 5. The initiative, dubbed I-522, calls for any food that is genetically modified or contains genetically modified products to be clearly labeled as such. Although this may seem to be a minor demand, I-522 and other bills like it face serious opposition from the largest GMO producers–biotech giants like Monsanto and DuPont. These companies engineer products that can withstand high levels of pesticides. Conveniently enough, they also happen to produce and sell these pesticides. In fact, the complete absence of labeling laws and regulations in the U.S. today is a direct result of these companies’ counter-attacks.  Last year, a California bill known as Proposition 37, which essentially proposed the same regulations as Washington’s I-522, was voted down in a narrow margin that didn’t reflect the disparity in financial backing between the bill’s proponents and opponents.

Last year, a California bill known as Proposition 37, which essentially proposed the same regulations as Washington’s I-522, was voted down in a narrow margin that didn’t reflect the disparity in financial backing between the bill’s proponents and opponents. According to Nathanael Johnson of grist.org, an environmental news website, supporters of this bill were financially outmatched by opponents who outspent them five to one with $42 million in the six weeks before the vote. Ultimately, GMO supporters only managed to shoot down the bill by 3 percent.

Monsanto claims that labeling initiatives are superfluous due to a lack of condemning results and inconclusive findings regarding the safety of GMO products. Its website insists that “mandatory labeling could imply that food products containing these ingredients are somehow inferior to their conventional or organic counterparts.”

Biotech companies also cite the cost of labeling as a reason for their opposition to these initiatives. In combatting Proposition 37 in California, the spokeswoman for the Against the Deceptive Food Labeling Scheme, Kathy Fairbanks, asserts that mandatory GMO labeling would “force California families to pay hundreds of dollars more in higher food prices, would cost millions in government bureaucracy, and would not provide any health and safety benefits.” Yet manufacturers are constantly obligated to update and alter their packaging, which the president and founder of Nature’s Path refers to as a “regular cost of doing business, a small one at that, …already built into our cost structure.” If cost were the real issue, Monsanto and other biogiants could simply put the millions they spend on
anti-label campaigns toward the allegedly prohibitive costs of labeling.

Meanwhile, the scientific community does not support biotech companies’ claims that their products are not at all harmful or unsafe. At the very least, the debate remains open, and according to Stacy Malkan, a spokeswoman of California’s Right to Know organization, “Many scientists are saying that in the face of scientific uncertainty, labeling is an important tool to help track potential health risks.” Indeed, without proper labeling of GMOs, there is no way to measure what effects these products are having on human health, as they are being consumed in unprecedented varieties and quantities.

Given the controversy surrounding newly produced biotech foods, the vote in Washington this October will demonstrate once again whether the American public, which has polled time and again in favor of labeling GMO products, will be able to actualize that demand in law. Will Monsanto and other biotech giants have the same sway in Washington with huge donations to anti-labeling campaigns, or will voters be able to withstand the influence of these donations in an unprecedented way? There is no denying that Washington’s vote on I-522 will make an impactful statement regarding America’s opinion on genetically modified foods. This vote will show whether or not America is ready to step up to the plate to keep modified mystery foods off of it.

Categories: ScienceTags: GMOs

Primary Sidebar

Recent Posts

  • Why South Africa Remains Unequal Thirty Years After Apartheid May 7, 2024
  • Skeptical of September February 8, 2024
  • Waterwheel February 7, 2024
  • Nineteen February 7, 2024
  • D.C.’s Most Expensive Retirement Home: Congress    February 7, 2024
  • Instagram

Archives

  • May 2024
  • February 2024
  • October 2023
  • April 2023
  • February 2023
  • December 2022
  • November 2022
  • October 2022
  • September 2022
  • May 2022
  • April 2022
  • February 2022
  • December 2021
  • November 2021
  • April 2021
  • March 2021
  • February 2021
  • December 2020
  • November 2020
  • October 2020
  • September 2020
  • April 2020
  • February 2020
  • January 2020
  • December 2019
  • November 2019
  • October 2019
  • May 2019
  • April 2019
  • March 2019
  • February 2019
  • January 2019
  • December 2018
  • November 2018
  • October 2018
  • August 2018
  • May 2018
  • April 2018
  • March 2018
  • February 2018
  • January 2018
  • December 2017
  • November 2017
  • October 2017
  • September 2017
  • June 2017
  • May 2017
  • April 2017
  • March 2017
  • February 2017
  • December 2016
  • November 2016
  • October 2016
  • May 2016
  • April 2016
  • March 2016
  • February 2016
  • January 2016
  • December 2015
  • November 2015
  • May 2015
  • April 2015
  • December 2014
  • October 2014
  • April 2014
  • March 2014
  • December 2013
  • November 2013
  • February 2012

Copyright © 2025 · The Bowdoin Review - A voice on campus for politics, society, and culture.